# Everolimus Dose Finding Study for Stage IV or Recurrent Cervical Cancer

> **NCT00967928** · PHASE1 · WITHDRAWN · sponsor: **Accelerated Community Oncology Research Network**

## Conditions studied

- Cervical Cancer

## Interventions

- **DRUG:** RAD001
- **DRUG:** Cisplatin
- **RADIATION:** External Beam Whole Pelvis Radiation Therapy

## Key facts

- **NCT ID:** NCT00967928
- **Lead sponsor:** Accelerated Community Oncology Research Network
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-12
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of enrollment
- **Last updated:** 2014-02-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00967928

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00967928, "Everolimus Dose Finding Study for Stage IV or Recurrent Cervical Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00967928. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*